John A. Stalfort III serves as Executive at Acumen Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, John A. Stalfort III has executed 8 insider transactions totaling $1.8M, demonstrating a bullish approach to their equity position. Their most recent transaction on May 29, 2024 involved receiving (via award) 49,220 shares valued at $0.
John A. Stalfort III currently holds 1,098,601 shares of Acumen Pharmaceuticals, Inc. (ABOS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John A. Stalfort III has been a net buyer of ABOS stock. They have purchased $1.8M and sold $0 worth of shares.
John A. Stalfort III's most recent insider trade was on May 29, 2024, when they sold 49,220 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Aug 16, 2023 | TSHA | $350.0K | Purchase | 388,889 | $0.90 | Discretionary |
| Aug 16, 2023 | TSHA | $350.0K | Purchase | 388,889 | $0.90 | Discretionary |
| Jul 5, 2022 | VRCA | $500.0K | Purchase | 238,095 | $2.10 | Discretionary |
| Jul 6, 2021 | ABOS | $560.0K | Purchase | 35,000 | $16.00 | Discretionary |
| Jul 6, 2021 | ABOS | $0 | Conversion | 131,595 | $N/A | Discretionary |
| Jul 6, 2021 | ABOS | $0 | Conversion | 130,180 | $N/A | Discretionary |